Trial intelligence / Profile preview

N-acetylcysteine in Bulimia Nervosa

NCT01033149Phase 3Terminated

Sponsor
Lindner Center of HOPE
Start
Dec 2009
Primary completion
Mar 2012
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in bulimia nervosa (BN), sponsored by Lindner Center of HOPE. Started Dec 2009; status: terminated.

02

Drugs

acetylcysteine
03

Conditions

bulimia nervosa (BN)

Beyond the preview

Go deeper on NCT01033149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01033149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call